pharyng
common
condit
last
sever
day
usual
result
selflimit
viral
infect
common
cold
although
occasion
pharyng
caus
bacteri
infect
commonli
report
symptom
sore
throat
antibiot
work
virus
case
caus
pharyng
often
prescrib
anyway
contribut
antimicrobi
resist
bacteria
becom
immun
antibiot
treatment
infect
becom
difficult
altern
treatment
could
help
reduc
inappropri
prescript
antibiot
pharyng
previou
studi
demonstr
antivir
painreliev
qualiti
antisept
lozeng
author
conduct
laboratori
base
studi
assess
abil
antisept
lozeng
kill
broad
rang
bacteria
known
caus
pharyng
found
lozeng
contain
two
antisept
ingredi
dissolv
solut
similar
human
saliva
mixtur
kill
pharyngitisassoci
bacteria
test
within
minut
result
suggest
patient
uncompl
bacteri
pharyng
may
benefit
antibacteri
painreliev
action
antisept
lozeng
includ
take
antibiot
addit
antisept
lozeng
may
relev
appropri
antibiot
pharyng
viral
origin
pharyng
associ
inflamm
one
common
reason
patient
seek
health
care
profession
acut
pharyng
predominantli
caus
viral
upper
respiratori
tract
infect
common
usual
selflimit
symptom
sore
throat
last
despit
antibiot
still
frequent
inappropri
use
treatment
pharyng
even
though
patient
consult
doctor
often
primarili
seek
reassur
symptomat
antibiot
ineffect
virus
case
offer
symptomat
relief
inappropri
antibiot
prescript
contribut
antimicrobi
resist
seriou
threat
global
public
consequ
need
nonantibiot
broad
antiinfect
effect
meet
patient
need
relief
symptom
antisept
class
antimicrobi
agent
kill
via
physic
action
addit
bactericid
activ
antisept
amylmetacresol
amc
alcohol
dcba
shown
antivir
effect
anestheticlik
establish
benefit
provid
symptomat
relief
bacteri
infect
contribut
pharyng
case
common
bacteri
caus
acut
pharyng
reason
legitim
antibiot
prescrib
prevent
complic
group
streptococcu
gabh
streptococcu
pyogen
respons
case
less
frequent
adult
rare
result
number
bacteria
also
implic
infect
throat
may
present
complic
patholog
repres
either
opportunist
infect
underli
medic
condit
less
common
speci
recov
patient
present
symptom
pharyng
clinic
diagnosi
pharyng
includ
fusobacterium
describ
recent
studi
true
pathogen
rather
colon
streptococcu
dysgalactia
subspeci
equisimili
caus
sever
recurr
although
insuffici
evid
role
dysgalactia
advers
moraxella
catarrhali
frequent
isol
patient
pharyng
combin
may
signific
consid
separ
studi
demonstr
catarrhali
potenti
adhes
pyogen
nasopharyng
bacteria
cultur
patient
pharyng
includ
haemophilu
arcanobacterium
opportunist
pathogen
staphylococcu
aureu
although
clinic
signific
aureu
associ
patient
diagnos
tonsil
f
necrophorum
appear
clinic
import
speci
preval
significantli
higher
subject
clinic
tonsil
compar
subject
without
aureu
also
identifi
common
caus
common
pathogen
isol
patient
undergo
tonsillectomi
due
recurr
h
influenza
similarli
recov
patient
tonsil
although
clinic
signific
current
nonantibiot
antimicrobi
treatment
could
potenti
benefit
patient
bacteri
pharyng
offer
antimicrobi
activ
also
symptomat
relief
vitro
activ
lozeng
formul
previous
investig
pyogen
studi
vitro
bactericid
activ
amcdcba
lozeng
broader
rang
potenti
pathogen
oropharyng
bacteria
assess
evalu
potenti
vivo
action
lozeng
organ
associ
pharyng
bactericid
assay
amc
mg
dcba
mg
lozeng
strepsil
honey
lemon
reckitt
benckis
healthcar
ltd
slough
uk
dissolv
ml
artifici
saliva
medium
meat
extract
vwr
intern
lutterworth
uk
yeast
extract
vwr
intern
proteas
pepton
oxoid
basingstok
uk
potassium
chlorid
fisher
scientif
loughborough
uk
sodium
chlorid
fisher
scientif
calcium
carbon
fisher
scientif
glucos
vwr
intern
mucin
porcin
stomach
type
ii
sigma
aldrich
gillingham
dorset
uk
ph
aureu
public
health
england
salisburi
uk
cultur
trypton
soya
agar
sgl
corbi
uk
pyogen
public
health
england
cultur
columbia
blood
agar
defibrin
sheep
blood
sgl
catarrhali
public
health
england
cultur
columbia
blood
agar
sgl
h
influenza
public
health
england
cultur
chocol
blood
agar
sgl
f
necrophorum
public
health
england
cultur
anaerob
blood
agar
faa
hors
blood
sgl
anaerob
haemolyticum
ncimb
aberdeen
uk
cultur
columbia
blood
agar
defibrin
sheep
blood
dysgalactia
lgc
teddington
uk
cultur
columbia
blood
agar
defibrin
sheep
blood
bactericid
assay
perform
follow
protocol
similar
clinic
laboratori
standard
institut
approv
specif
inoculum
cultur
prepar
challeng
organ
give
approxim
popul
colonyform
unit
cfu
ml
salin
sodium
chlorid
fisher
scientif
one
inoculum
suspens
prepar
replic
test
test
sampl
ml
prepar
inocul
ml
inoculum
suspens
solut
vortex
thoroughli
mix
test
contact
time
consist
time
lozeng
take
dissolv
remov
ml
sampleinocula
mixtur
transfer
ml
neutral
diluent
pepton
water
vwr
intern
sodium
chlorid
fisher
scientif
lecithin
mp
biomed
illkirchgraffenstaden
franc
polysorb
univar
bradford
uk
ph
neutral
valid
carri
test
organ
solut
serial
dilut
plate
onto
appropri
agar
medium
incub
minimum
day
posit
control
sampl
ml
artifici
saliva
medium
ml
test
inoculum
organ
also
prepar
without
exposur
test
sampl
assay
time
point
test
control
count
perform
confirm
total
popul
cultur
suspens
use
test
replic
test
control
use
calcul
log
reduct
exposur
test
sampl
mean
log
reduct
cfu
per
millilit
calcul
three
test
replic
test
organ
evid
bactericid
activ
record
time
point
tabl
figur
test
control
count
demonstr
test
method
media
affect
surviv
organ
pyogen
h
influenza
haemolyticum
f
necrophorum
decreas
cfuml
minut
exceed
decreas
wherea
greater
reduct
record
minut
dysgalactia
catarrhali
minut
aureu
addit
time
point
sd
tabl
replic
small
cfuml
indic
consist
reproduc
observ
studi
examin
bactericid
action
antisept
lozeng
contain
amc
dcba
organ
test
includ
gramposit
cocci
pyogen
aureu
dysgalactia
bacilli
haemolyticum
well
gramneg
cocci
catarrhali
bacilli
h
influenza
f
necrophorum
repres
broad
rang
bacteri
cell
structur
sensit
result
demonstr
amcdcba
lozeng
exhibit
broad
bactericid
activ
rang
organ
implic
pharyng
rapid
activ
observ
consist
time
taken
lozeng
dissolv
test
organ
evid
bactericid
activ
amcdcba
lozeng
record
time
point
particular
interest
robust
bactericid
activ
pyogen
frequent
caus
bacteri
reduct
exceed
achiev
minut
pyogen
h
influenza
haemolyticum
f
necrophorum
minut
dysgalactia
catarrhali
minut
aureu
bactericid
activ
amcdcba
lozeng
within
period
import
consist
durat
lozeng
remain
mouth
furthermor
activ
ingredi
also
test
expect
concentr
achiev
lozeng
dissolv
mouth
assum
volum
ml
saliva
previou
vitro
evalu
bactericid
activ
antisept
lozeng
dcba
mg
menthol
mg
amc
mg
dcba
mg
amc
mg
pyogen
aureu
demonstr
antibacteri
amc
dcba
formul
highli
activ
bacteria
test
within
minut
exposur
contrast
slow
weak
action
local
antibiot
data
gener
studi
support
expand
upon
previous
publish
observ
provid
evid
effect
broader
rang
bacteri
speci
vitro
condit
includ
knowledg
clinic
patholog
pharyng
continu
evolv
repres
either
opportunist
infect
underli
medic
condit
data
likewis
complement
recent
studi
show
vitro
viricid
effect
lozeng
contain
amcdcba
activ
ingredi
free
substanc
parainfluenza
viru
type
cytomegaloviru
respiratori
syncyti
viru
influenza
sever
acut
respiratori
syndrom
addit
antimicrobi
activ
amc
dcba
proven
provid
relief
symptom
pharyng
particularli
sore
throat
like
demonstr
local
anestheticlik
action
voltageg
neuron
sodium
therefor
may
benefit
patient
present
either
bacteri
viral
pharyng
furthermor
reliev
symptom
manag
patient
expect
number
instanc
inappropri
antibiot
prescrib
viral
pharyng
may
reduc
limit
studi
observ
perform
vitro
therefor
fulli
reflect
environ
throat
exampl
throat
may
contain
multipl
microorgan
wherea
studi
test
bactericid
activ
organ
isol
role
patient
immun
system
swallow
action
antimicrobi
activ
lozeng
activ
ingredi
also
determin
use
vitro
methodolog
howev
incid
bacteria
relevantli
low
gener
popul
therefor
studi
bactericid
activ
amcdcba
vivo
challeng
consequ
vitro
approach
advantag
allow
rapid
gener
robust
data
multipl
organ
simultan
use
evalu
potenti
amcdcba
efficaci
vivo
data
show
amcdcba
lozeng
demonstr
bactericid
activ
test
organ
repres
broad
rang
bacteri
cell
structur
minut
achiev
greater
kill
test
organ
within
minut
consist
durat
lozeng
remain
mouth
therefor
patient
uncompl
bacteri
pharyng
includ
take
antibiot
lowrisk
popul
without
addit
risk
factor
may
benefit
antisept
action
amcdcba
rang
bacteri
speci
associ
pharyng
case
pharyng
requir
antibiot
typic
selflimit
often
viral
origin
therefor
overthecount
antisept
like
amcdcba
may
appropri
unless
condit
deterior
streptococc
infect
diagnos
data
gener
analyz
studi
includ
manuscript
